Nutraveris
Wednesday, April 17, 2019
Category : NEWS | Author : experts | Comment : No Comments
Tags:

Are you ready to discover the future way to develop

new products thanks to Artificial Intelligence?

 

Let’s book a meeting at Vitafoods with our experts

to discover our latest innovations:

 

NOL Datasolution , to CREATE your new products

thanks to regulatory, scientific data & products benchmarking.

 

NOL Compliance to LAUNCH your products into the different EU member states,

thanks to compliance, labeling generation and monitoring & update at anytime

 

See here how NOL Solutions will help you:

Click here to see the video

 

Depending on your availability during these 3 days of show, you can schedule an appointment with our team,

booth F60, using the form below:

to book an appointment, it’s here

 

 

Come and meet our team at Vitafoods, Geneva, May 7th-9th, Nutraveris’ experts will be pleased to welcome you booth F60

See you soon, booth F60 !

 

Nutraveris’ team

 

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, April 16, 2019
Category : NEWS, REGULATORY | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

Following a request from UK, on 10 April 2019, the European Council agreed to a further extension to allow for the ratification of the Withdrawal Agreement by both Parties.

Such an extension should last as long as necessary and, in any event, no longer than 31 October 2019. The European Council also recalled that, under Article 50, the Withdrawal Agreement may enter into force on an earlier date, should the Parties complete their respective ratification procedures before 31 October 2019.

 

Brexit: further extension until 31 October 2019 at the latest

 

Consequently, the withdrawal should take place on the first day of the month following the completion of the ratification procedures.

One consequence is that the United Kingdom has to hold elections to the European Parliament in accordance with applicable Union law.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, April 11, 2019
Category : NEWS, INGREDIENTS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

This randomized, single-blind, placebo-controlled study evaluated among 70 women with acute uncomplicated cystitis the effects of daily supplementation during 3 days with 2000 mg of spray-dried aqueous extract of green tea or placebo (Starch) along with antibiotherapy (trimethoprim-sulfamethoxazole).

 Green tea as adjunctive therapy for acute uncomplicated cystitis in women

Women in the green tea group showed a decrease in the prevalence of cystitis symptoms compared to baseline, from 68% to 61% after 1 day, to 34% after 2 days and to 2% after 3 days. This prevalence of cystitis symptoms decrease is significantly higher in the green tea group than in the placeob group at all measurement point (all p < 0.01). Also a significant improvement in urinalysis results (abnormal urine color, pyuria, bacteruria, all p < 0.0001) were noted in the green tea group compared to the placebo group after 3 days of supplementation.

 

Authors concluded that green tea extract is efficient as adjunctive therapy for the management of cystitis symptoms in women with acute uncomplicated cystitis.

 

Kheirabadi Z, Mehrabani M, Sarafzadeh F, Dabaghzadeh F, Ahmadinia N. Green tea as an adjunctive therapy for treatment of acute uncomplicated cystitis in women: A randomized clinical trial. Complementary Therapies in Clinical Practice 34 (2019) 13–16

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, April 9, 2019
Category : NEWS, REGULATORY | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

Anses recommendations on products with glucosamine and chondroitin

 

In a scientific opinion published in March 2019, Anses recommends that the following population groups should not consume food supplements with glucosamine or chondroitin sulfate:

  • Diabetic or pre-diabetic individuals, as well as those who are asthmatic or are treated with vitamin K antagonists (VKA).
  • People with a food allergy to crustaceans or insects (glucosamine-based food supplements only).
  • People on sodium, potassium or calcium-restricted diets, as these supplements can be an important source of these elements.
  • Pregnant or breastfeeding women, as well as children, due to insufficient data on the safety of these products.

ANSES recommends that measures be taken by manufacturers to better inform consumers about the risks associated with the consumption of these food supplements by these specific populations.

It is possible that the French Authorities (DGCCRF) will recommend the labelling of warnings according to this scientific opinion.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, April 4, 2019
Category : NEWS, INGREDIENTS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

This randomized, double-blinded and placebo-controlled trial has evaluated the effects of green cardamom (3 g/day for 10 weeks) in 83 overweight or obese type 2 diabetic patients. The authors examined the effects of the supplementation in anthropometric parameters, glycemic indices and blood lipids. Serum sirtuin-1 level has also been assessed.

Cardamon

In comparison to the placebo, green cardamom has reduced plasma HbA1c (-0.4%), insulin (-2.8 µIU/dL) and triglycerides (-39.9 mg/dL). Moreover, an improvement in insulin sensitivity has been noted, highlighted by the reduction in the HOMA-IR indice (-1.7). Finally, an increase in sirtuin-1 level has been measured.

 

The authors concluded that green cardamom may improve some metabolic parameters in overweight or obese type 2 diabetic patients by increasing the Sirtuin-1 level.

 

 

Aghasi M, Koohdani F, Qorbani M, Nasli-Esfahani E, Ghazi-Zahedi S, Khoshamal H, Keshavarz A, Sotoudeh G. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial. J Sci Food Agric. 2019 Jan 30.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87